by
Gus Iversen, Editor in Chief | May 02, 2014
A more certain future for thrombolysis patients
With further funding already secured from the Wellcome Trust, the research team at Imperial College London has started making preparations for a second study. This time around they intend to pool their subjects from all across London (not just one hospital, as it had been in the initial study) and test their software on over 2,000 subjects instead of 116. Their immediate goal is to improve their success ratio by incorporating larger scale cohorts and applying their software to more advanced imaging.
Ad Statistics
Times Displayed: 46408
Times Visited: 1304 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
In the long run, the researchers hope that doctors will be able to successfully administer thrombolysis to a larger number of their patients. Because of the risk involved, only about 20 percent of ischemic stroke patients currently receive the treatment. Reducing or eliminating the danger associated with it would represent a breakthrough in the way clinicians approach stroke cases. With over 15 million people affected by stoke each year worldwide, there is no small demand for safe and effective treatment.
Back to HCB News
